Mainstream

Lantheus increases to 12.16% shareholding in Radiopharm Theranostics

Lantheus increases to 12.16% shareholding in Radiopharm Theranostics

Post Contentlnth, radxRead More

You might also be interested in reading ICP Retreats From $5.75 High Amid Heavy Distribution.

January 10, 2025
In Mainstream